NCT03984071View on ClinicalTrials.gov

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

ST Elevation Myocardial Infarction

All Listed Sponsors

lead

Dongying Zhang

OTHER

NCT03984071 - The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI | Biotech Hunter | Biotech Hunter